成纤维细胞生长因子受体1可作为类风湿关节炎患者终末效应性外周辅助性T细胞的潜在标志物
研究比较了类风湿关节炎(RA)患者与健康对照外周血中FGFR1阳性CD4+ T细胞比例,并对滑膜CD4+ T细胞进行单细胞RNA测序。结果显示RA患者外周血FGFR1阳性CD4+ T细胞比例高于健康对照(P=0.0035),该细胞群也存在于活动性RA患者滑膜中,且优先表达FGFR1的外周辅助性T(Tph)细胞呈现终末效应细胞表型并表达IL-21和IFN-γ。
要点
- RA患者外周血FGFR1阳性CD4+ T细胞比例高于健康对照(P=0.0035)。
- 活动性RA患者滑膜中亦存在FGFR1阳性CD4+ T细胞。
- FGFR1阳性Tph细胞呈终末效应表型并表达IL-21和IFN-γ。
核心结论
- 研究提供证据表明FGFR1标记RA患者的终末效应性Tph细胞。
研究设计与样本
- 研究检测了外周血和滑膜中FGFR1阳性CD4+ T细胞的丰度,并对滑膜CD4+ T细胞进行单细胞RNA测序以表征FGFR1阳性细胞,同时用流式细胞术检测T细胞活化状态和细胞因子产生。
主要发现
- RA患者外周血中FGFR1阳性CD4+ T细胞百分比高于健康对照(P=0.0035)。
- FGFR1阳性CD4+ T细胞也存在于活动性RA患者滑膜中。
- 单细胞RNA测序结果显示外周辅助性T(Tph)细胞优先表达FGFR1。
- 这些FGFR1阳性Tph细胞呈现终末效应细胞表型。
- 外周血FGFR1阳性CD4+ T细胞表达IL-21和IFN-γ。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: RA is an autoimmune disease characterized by destructive polyarthritis. CD4+ T cells are pivotal to its pathogenesis, and our previous study revealed the expression of fibroblast growth factor receptor 1 (FGFR1) is modulated by MTX treatment in CD4+ T cells of RA patients; however, the roles of FGFR1 in CD4+ T cells in the pathogenesis of RA is unclear. Therefore, in this study, we aimed to characterize FGFR1-positive CD4+ T cells in RA patients. METHODS: The abundance of FGFR1-positive CD4+ T cells in peripheral blood and synovium was determined. Single-cell RNA sequencing (scRNA-seq) was performed on synovial CD4+ T cells to characterize FGFR1-positive cells. In addition, T cell activation status and cytokine production were determined using flow cytometry. RESULTS: The percentage of FGFR1-positive CD4+ T cells in the peripheral blood was higher in RA patients than in healthy controls (P =0.0035). They were also present in the synovium of active RA patients. The results of scRNA-seq revealed that peripheral Th (Tph) cells preferentially expressed FGFR1. Additionally, these FGFR1-positive Tph cells displayed a terminal effector cell phenotype. Consistent with this finding, FGFR1-positive CD4+ T cells in peripheral blood expressed IL-21 and IFN-γ. CONCLUSION: Our study provides evidence that FGFR1 marks terminal effector Tph cells in patients with RA.
引用
- Etori K, Tanaka S, Tamura J, et al. Fibroblast growth factor receptor 1 as a potential marker of terminal effector peripheral T helper cells in rheumatoid arthritis patients. Rheumatology (Oxford). 2023. PMID: 37184877. doi:10.1093/rheumatology/kead220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。